Will Yuhan and Gilead cooperate for the hepatitis C drug, ‘Sovaldi’?
The alliance of Gilead and Yuhan Corporation, which has shown the perfect match in the hepatitis B market, has attracted attention for possibility to keep the trend in the hepatitis C treatment market.
So far, at least, it has displayed a positive circumstance. According to the industry concerne...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
